We have chosen a different time
window for benzodiazepines, because in The Netherlands, benzodiazepines are dispensed for periods up to 1 month and other drugs for periods up to 3 months. Statistical analysis Conditional logistic regression analysis was used to estimate the risk of hip/femur fracture associated with the use of TCAs, SSRIs and the various confounding variables (SAS version 9.1.3, PHREG procedure) and were expressed as odds ratios (OR) with corresponding 95% confidence intervals (CI). Adjusted odds ratios (ORadj) for hip/femur fracture were estimated by comparing anti-depressant use with no use using conditional logistic regression analysis. Final regression models were determined by stepwise backward elimination C188-9 using a significance level of 0.05. We stratified the study population to assess the risk with current use by age and sex. Further analyses were conducted to evaluate the risk of fracture associated with current exposure to anti-depressants
versus no use grouping current users according to the daily dose of anti-depressant prescribed buy Belinostat and according to the degree of 5-HTT inhibition expected. Smoothing spline regression plots (SAS version 9.1.3) were used to visualise the longitudinal relationship Semaxanib nmr between the risk of fracture and (a) the time between the index date and last dispensing of an anti-depressant (recency of use) and (b) the duration of continuous use. The population attributable risk (PAR) was estimated Prostatic acid phosphatase using the following formula: $$\textPAR\% = \frac\textPe\left( \textOR – 1 \right)1
+ \textPe\left( \textOR – 1 \right) \times 100.$$ The prevalence (Pe) of anti-depressant use was derived from national prescribing figures in 2003, www.gipdatabank.nl. Results We identified 6,763 patients who suffered a hip/femur fracture. These cases were matched to 26,341 controls. The mean age of cases and controls was 75 years and 73% were female (Table 2). The mean period of time with prescription information before the index date was 4.1 years. Prescriptions for paroxetine accounted for 50% of the prescriptions issued for an SSRI (25,131/50,287). Most of the other SSRI prescriptions were for fluoxetine (23.4%) or fluvoxamine (20.3%). Amitriptyline (46.6%) and clomipramine (23.1%) accounted for the majority of TCA prescriptions (n = 59,836).